Cover Image
Market Research Report
Product code 
1047088

Europe Clinical Trial Management Market Forecast 2022-2030

Published: | Inkwood Research | 166 Pages | Delivery time: 2-3 business days

Price

Back to Top
Europe Clinical Trial Management Market Forecast 2022-2030
Published: January 19, 2022
Inkwood Research
Content info: 166 Pages
Delivery time: 2-3 business days
  • Description
  • Table of Contents
  • List of Tables

KEY FINDINGS

The Europe clinical trial management market is predicted to record a CAGR of 13.00% during the forecast period, 2022-2030. The presence of developed healthcare infrastructure and key players are significant growth drivers of the market.

MARKET INSIGHTS

Germany, Denmark, Spain, Sweden, Hungary, Italy, Russia, France, the United Kingdom, and Rest of Europe, are assessed for the growth evaluation of the Europe clinical trial management market. In Germany, organizations invest a large share of their revenues in R&D across several application industries, like clinical research genomics, proteomics, and drug discovery. The country also has an active genomics sector R&D and is increasingly prioritizing research labs. Germany leads globally in terms of industry-sponsored clinical trials. This is attributed to the transparent and reliable approval processes and high level of accuracy at German trial sites. Also, the well-established network of good to excellent universities and faculties, and non-university research facilities, benefit clinical trials. Such factors supplement market growth in Germany.

In Russia, the government adopted the 'Strategy 2020' to enhance the pharma sector's production capacity. Pharmaceutical companies are investing in the market. The pharmaceutical industry is projected to be driven by investments made by private players, rising healthcare expenditure, and increased government support. Also, several companies are collaborating with local universities to improve R&D capabilities. Further, the elderly population is set to double by 2050, increasing the burden on healthcare, pension, and long-term care systems. Therefore, there is a need for a robust and competent healthcare system. Moreover, the Russian market offers a competitive advantage to companies looking for alternative markets due to its developing economy. Such factors are expected to benefit the Russian market growth.

COMPETITIVE INSIGHTS

Some of the major players in the market include: Oracle Corporation, Mednet Solutions Inc, Parexel International Corporation, Bioclinica Inc, IBM Corporation, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments
Product Code: 24391

TABLE OF CONTENTS

1. RESEARCH SCOPE & METHODOLOGY

  • 1.1. STUDY OBJECTIVES
  • 1.2. SCOPE OF STUDY
  • 1.3. METHODOLOGY
  • 1.4. ASSUMPTIONS & LIMITATIONS

2. EXECUTIVE SUMMARY

  • 2.1. MARKET SIZE & ESTIMATES
  • 2.2. MARKET OVERVIEW

3. MARKET DYNAMICS

  • 3.1. PARENT MARKET ANALYSIS - HEALTHCARE
  • 3.2. MARKET SCOPE
  • 3.3. KEY DRIVERS
    • 3.3.1. OUTSOURCING OF CLINICAL TRIALS
    • 3.3.2. GROWING NUMBER OF CLINICAL TRIALS
    • 3.3.3. AWARENESS REGARDING THE BENEFITS OF USING CTM SOFTWARE
    • 3.3.4. INCIDENCES OF CHRONIC DISEASES
    • 3.3.5. RESEARCH & DEVELOPMENT
  • 3.4. KEY RESTRAINTS
    • 3.4.1. SCARCITY OF SKILLED HEALTHCARE PROFESSIONALS
    • 3.4.2. COST OF IMPLEMENTATION
    • 3.4.3. SECURITY CONCERNS

4. KEY ANALYTICS

  • 4.1. IMPACT OF COVID-19 ON CLINICAL TRIAL MANAGEMENT MARKET
  • 4.2. KEY MARKET TRENDS
  • 4.3. PORTER'S FIVE FORCES ANALYSIS
    • 4.3.1. BUYERS POWER
    • 4.3.2. SUPPLIERS POWER
    • 4.3.3. SUBSTITUTION
    • 4.3.4. NEW ENTRANTS
    • 4.3.5. INDUSTRY RIVALRY
  • 4.4. OPPORTUNITY MATRIX
  • 4.5. VENDOR LANDSCAPE

5. MARKET BY END-USER

  • 5.1. PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES
  • 5.2. CLINICAL RESEARCH ORGANIZATIONS
  • 5.3. HEALTHCARE PROVIDERS

6. MARKET BY PRODUCT TYPE

  • 6.1. ENTERPRISE-BASED CTM
  • 6.2. SITE-BASED CTM

7. MARKET BY DEPLOYMENT MODEL

  • 7.1. WEB-BASED DEPLOYMENT
  • 7.2. ON-PREMISE DEPLOYMENT
  • 7.3. CLOUD-BASED DEPLOYMENT

8. MARKET BY COMPONENT

  • 8.1. SOFTWARE
  • 8.2. HARDWARE
  • 8.3. SERVICES

9. GEOGRAPHICAL ANALYSIS

  • 9.1. EUROPE
    • 9.1.1. MARKET SIZE & ESTIMATES
    • 9.1.2. KEY GROWTH ENABLERS
    • 9.1.3. KEY CHALLENGES
    • 9.1.4. KEY PLAYERS
    • 9.1.5. COUNTRY ANALYSIS
      • 9.1.5.1. UNITED KINGDOM
      • 9.1.5.2. GERMANY
      • 9.1.5.3. FRANCE
      • 9.1.5.4. ITALY
      • 9.1.5.5. RUSSIA
      • 9.1.5.6. DENMARK
      • 9.1.5.7. HUNGARY
      • 9.1.5.8. SWEDEN
      • 9.1.5.9. SPAIN
      • 9.1.5.10. REST OF EUROPE

10. COMPETITIVE LANDSCAPE

  • 10.1. KEY STRATEGIC DEVELOPMENTS
    • 10.1.1. MERGERS & ACQUISITIONS
    • 10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
    • 10.1.3. PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS
  • 10.2. COMPANY PROFILES
    • 10.2.1. ADVARRA (FORTE RESEARCH SYSTEMS INC)
    • 10.2.2. ARISGLOBAL LLC
    • 10.2.3. BIOCLINICA INC
    • 10.2.4. BIO-OPTRONICS INC
    • 10.2.5. IBM CORPORATION
    • 10.2.6. MEDIDATA SOLUTIONS INC
    • 10.2.7. MEDNET SOLUTIONS INC
    • 10.2.8. ORACLE CORPORATION
    • 10.2.9. PAREXEL INTERNATIONAL CORPORATION
    • 10.2.10. VEEVA SYSTEMS INC

LIST OF TABLES

  • TABLE 1: MARKET SNAPSHOT - CLINICAL TRIAL MANAGEMENT
  • TABLE 2: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 3: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY END-USER, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 4: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 5: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY PRODUCT TYPE, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 6: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODEL, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 7: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY DEPLOYMENT MODEL, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 8: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 9: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY COMPONENT, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 10: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, HISTORICAL YEARS, 2018-2021 (IN $ MILLION)
  • TABLE 11: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY COUNTRY, FORECAST YEARS, 2022-2030 (IN $ MILLION)
  • TABLE 12: KEY PLAYERS OPERATING IN EUROPE CLINICAL TRIAL MANAGEMENT MARKET
  • TABLE 13: LIST OF MERGERS & ACQUISITIONS
  • TABLE 14: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
  • TABLE 15: LIST OF PARTNERSHIPS, CONTRACTS/AGREEMENTS & COLLABORATIONS

LIST OF FIGURES

  • FIGURE 1: KEY MARKET TRENDS
  • FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
  • FIGURE 3: OPPORTUNITY MATRIX
  • FIGURE 4: VENDOR LANDSCAPE
  • FIGURE 5: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY END-USER, IN 2021
  • FIGURE 6: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES, 2022-2030 (IN $ MILLION)
  • FIGURE 7: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY CLINICAL RESEARCH ORGANIZATIONS, 2022-2030 (IN $ MILLION)
  • FIGURE 8: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY HEALTHCARE PROVIDERS, 2022-2030 (IN $ MILLION)
  • FIGURE 9: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY PRODUCT TYPE, IN 2021
  • FIGURE 10: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY ENTERPRISE-BASED CTM, 2022-2030 (IN $ MILLION)
  • FIGURE 11: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY SITE-BASED CTM, 2022-2030 (IN $ MILLION)
  • FIGURE 12: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY DEPLOYMENT MODEL, IN 2021
  • FIGURE 13: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY WEB-BASED DEPLOYMENT, 2022-2030 (IN $ MILLION)
  • FIGURE 14: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY ON-PREMISE DEPLOYMENT, 2022-2030 (IN $ MILLION)
  • FIGURE 15: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY CLOUD-BASED DEPLOYMENT, 2022-2030 (IN $ MILLION)
  • FIGURE 16: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, GROWTH POTENTIAL, BY COMPONENT, IN 2021
  • FIGURE 17: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY SOFTWARE, 2022-2030 (IN $ MILLION)
  • FIGURE 18: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY HARDWARE, 2022-2030 (IN $ MILLION)
  • FIGURE 19: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, BY SERVICES, 2022-2030 (IN $ MILLION)
  • FIGURE 20: EUROPE CLINICAL TRIAL MANAGEMENT MARKET, COUNTRY OUTLOOK, 2021 & 2030 (IN %)
  • FIGURE 21: UNITED KINGDOM CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 22: GERMANY CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 23: FRANCE CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 24: ITALY CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 25: RUSSIA CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 26: DENMARK CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 27: HUNGARY CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 28: SWEDEN CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 29: SPAIN CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)
  • FIGURE 30: REST OF EUROPE CLINICAL TRIAL MANAGEMENT MARKET, 2022-2030 (IN $ MILLION)